Latvia Antirheumatic Medicine Sales is set to reach $22.88 Million by 2026 from $20.9 Million, is expected to increase 5% per year. Germany, Spain and Canada respectively were numbers 2, 3 and 4 in this ranking.
How does Latvia perform in Anti Rheumatic?
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Latvia
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Latvia
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Use in Latvia
- Units (Defined Daily Dosage) Per Thousand Persons Per Day
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Latvia
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Latvia
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Latvia
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Import of Heterocyc Compounds and Quinoline Ring to Latvia
- US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Export of Heterocyc Compounds and Quinoline Ring from Latvia
- US Dollars
- 2024 to 2028
- ReportLinker Research